In order to explore the structure–activity relationships in the acronycine series, simplified analogues of cis-1, 2-diacetoxy-1, 2-dihydroacronycine and cis-1, 2-diacetoxy-1, 2- dihydrobenzo [b] acronycine (S23906-1, under clinical trials) lacking the fused pyran ring, but possessing an acetoxymethyl leaving group at position 4 were prepared. These new analogues only displayed marginal antiproliferative activity compared to the parent ...
[Hawkins, David G.; Meth-Cohn, Otto Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983 , p. 2077 - 2087]
[Hawkins, David G.; Meth-Cohn, Otto Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983 , p. 2077 - 2087]
[Hawkins, David G.; Meth-Cohn, Otto Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983 , p. 2077 - 2087]